Ninety-Six—Week Efficacy of Combination Therapy with Lamivudine and Tenofovir in Patients Coinfected with HIV-1 and Wild-Type Hepatitis B Virus
We describe 6 patients who were coinfected with human immunodeficiency virus (HIV) type 1 and wild-type hepatitis B virus (HBV), in whom complete and sustained antiviral activity against wild-type HBV strains was attained during 96 weeks of combination therapy with lamivudine and tenofovir. The use...
Gespeichert in:
| Veröffentlicht in: | Clinical infectious diseases 2004-10, Vol.39 (7), p.1062-1064 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1064 |
|---|---|
| container_issue | 7 |
| container_start_page | 1062 |
| container_title | Clinical infectious diseases |
| container_volume | 39 |
| creator | Bani-Sadr, F. Palmer, P. Scieux, C. Molina, J. M. |
| description | We describe 6 patients who were coinfected with human immunodeficiency virus (HIV) type 1 and wild-type hepatitis B virus (HBV), in whom complete and sustained antiviral activity against wild-type HBV strains was attained during 96 weeks of combination therapy with lamivudine and tenofovir. The use of combination therapy with lamivudine and tenofovir for the treatment of HBV infection is very promising in the treatment of HIV/HBV coinfection. |
| doi_str_mv | 10.1086/424012 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_66955897</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4462847</jstor_id><oup_id>10.1086/424012</oup_id><sourcerecordid>4462847</sourcerecordid><originalsourceid>FETCH-LOGICAL-c453t-2b2e3b5bf2cb761316193a6bd4b1b7dc29acf39e2bc1d91c7618607d48bff1e93</originalsourceid><addsrcrecordid>eNqF0ctu1TAQBuAIgegFeAKEzAJ2Ad_tLMtRSyodcRGhRWwi27FVtycX7KQ0O14BiSfkSXDJUc8KsfJI8_1jjSbLniD4CkHJX1NMIcL3sn3EiMg5K9D9VEMmcyqJ3MsOYryEECEJ2cNsDzEqsOR4P_v5znd2nPNP_ub3j1_n1l6BY-e8UWYGvQOrvtW-U6PvO1Bd2KCGGXz34wVYq9ZfT00KA9U1oLJd7_prH4DvwIfkbTfGlPads2a0zRIqT89y9Nef-02TV_NgQWmHxEcfwRtw5sMUH2UPnNpE-3j7HmafT46rVZmv3789XR2tc0MZGXOssSWaaYeNFhwRxFFBFNcN1UiLxuBCGUcKi7VBTYFMMpJD0VCpnUO2IIfZy2XuEPpvk41j3fpo7GajOttPsea8YEwW4r8QCUEIhHIHTehjDNbVQ_CtCnONYH17pXq5UoLPthMn3dpmx7ZnSeDFFqho1MYF1Rkfd45jiAVGyT1fXD8N__7s6WIu49iHO0Upx5LebpcvbR9He3PXVuGq5oIIVpdfvtbrirGySMVH8gfS_L04</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17733008</pqid></control><display><type>article</type><title>Ninety-Six—Week Efficacy of Combination Therapy with Lamivudine and Tenofovir in Patients Coinfected with HIV-1 and Wild-Type Hepatitis B Virus</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Bani-Sadr, F. ; Palmer, P. ; Scieux, C. ; Molina, J. M.</creator><creatorcontrib>Bani-Sadr, F. ; Palmer, P. ; Scieux, C. ; Molina, J. M.</creatorcontrib><description>We describe 6 patients who were coinfected with human immunodeficiency virus (HIV) type 1 and wild-type hepatitis B virus (HBV), in whom complete and sustained antiviral activity against wild-type HBV strains was attained during 96 weeks of combination therapy with lamivudine and tenofovir. The use of combination therapy with lamivudine and tenofovir for the treatment of HBV infection is very promising in the treatment of HIV/HBV coinfection.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/424012</identifier><identifier>PMID: 15472862</identifier><identifier>CODEN: CIDIEL</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Adenine - analogs & derivatives ; Adenine - therapeutic use ; Adult ; AIDS ; Anti-HIV Agents - therapeutic use ; Antibodies ; Biological and medical sciences ; DNA ; Drug Therapy, Combination ; Female ; Hepatitis antigens ; Hepatitis B ; Hepatitis B - complications ; Hepatitis B - drug therapy ; Hepatitis B virus ; HIV ; HIV 1 ; HIV Infections - complications ; HIV Infections - drug therapy ; HIV/AIDS ; Human immunodeficiency virus 1 ; Human viral diseases ; Humans ; Infections ; Infectious diseases ; Lamivudine - therapeutic use ; Male ; Medical sciences ; Middle Aged ; Organophosphonates - therapeutic use ; RNA ; Tenofovir ; Viral diseases ; Viral diseases of the digestive system ; Viral diseases of the lymphoid tissue and the blood. Aids ; Viral hepatitis</subject><ispartof>Clinical infectious diseases, 2004-10, Vol.39 (7), p.1062-1064</ispartof><rights>Copyright 2004 The Infectious Diseases Society of America</rights><rights>2004 by the Infectious Diseases Society of America 2004</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c453t-2b2e3b5bf2cb761316193a6bd4b1b7dc29acf39e2bc1d91c7618607d48bff1e93</citedby><cites>FETCH-LOGICAL-c453t-2b2e3b5bf2cb761316193a6bd4b1b7dc29acf39e2bc1d91c7618607d48bff1e93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4462847$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4462847$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16202721$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15472862$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bani-Sadr, F.</creatorcontrib><creatorcontrib>Palmer, P.</creatorcontrib><creatorcontrib>Scieux, C.</creatorcontrib><creatorcontrib>Molina, J. M.</creatorcontrib><title>Ninety-Six—Week Efficacy of Combination Therapy with Lamivudine and Tenofovir in Patients Coinfected with HIV-1 and Wild-Type Hepatitis B Virus</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><description>We describe 6 patients who were coinfected with human immunodeficiency virus (HIV) type 1 and wild-type hepatitis B virus (HBV), in whom complete and sustained antiviral activity against wild-type HBV strains was attained during 96 weeks of combination therapy with lamivudine and tenofovir. The use of combination therapy with lamivudine and tenofovir for the treatment of HBV infection is very promising in the treatment of HIV/HBV coinfection.</description><subject>Adenine - analogs & derivatives</subject><subject>Adenine - therapeutic use</subject><subject>Adult</subject><subject>AIDS</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antibodies</subject><subject>Biological and medical sciences</subject><subject>DNA</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Hepatitis antigens</subject><subject>Hepatitis B</subject><subject>Hepatitis B - complications</subject><subject>Hepatitis B - drug therapy</subject><subject>Hepatitis B virus</subject><subject>HIV</subject><subject>HIV 1</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - drug therapy</subject><subject>HIV/AIDS</subject><subject>Human immunodeficiency virus 1</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Lamivudine - therapeutic use</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Organophosphonates - therapeutic use</subject><subject>RNA</subject><subject>Tenofovir</subject><subject>Viral diseases</subject><subject>Viral diseases of the digestive system</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Viral hepatitis</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0ctu1TAQBuAIgegFeAKEzAJ2Ad_tLMtRSyodcRGhRWwi27FVtycX7KQ0O14BiSfkSXDJUc8KsfJI8_1jjSbLniD4CkHJX1NMIcL3sn3EiMg5K9D9VEMmcyqJ3MsOYryEECEJ2cNsDzEqsOR4P_v5znd2nPNP_ub3j1_n1l6BY-e8UWYGvQOrvtW-U6PvO1Bd2KCGGXz34wVYq9ZfT00KA9U1oLJd7_prH4DvwIfkbTfGlPads2a0zRIqT89y9Nef-02TV_NgQWmHxEcfwRtw5sMUH2UPnNpE-3j7HmafT46rVZmv3789XR2tc0MZGXOssSWaaYeNFhwRxFFBFNcN1UiLxuBCGUcKi7VBTYFMMpJD0VCpnUO2IIfZy2XuEPpvk41j3fpo7GajOttPsea8YEwW4r8QCUEIhHIHTehjDNbVQ_CtCnONYH17pXq5UoLPthMn3dpmx7ZnSeDFFqho1MYF1Rkfd45jiAVGyT1fXD8N__7s6WIu49iHO0Upx5LebpcvbR9He3PXVuGq5oIIVpdfvtbrirGySMVH8gfS_L04</recordid><startdate>20041001</startdate><enddate>20041001</enddate><creator>Bani-Sadr, F.</creator><creator>Palmer, P.</creator><creator>Scieux, C.</creator><creator>Molina, J. M.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20041001</creationdate><title>Ninety-Six—Week Efficacy of Combination Therapy with Lamivudine and Tenofovir in Patients Coinfected with HIV-1 and Wild-Type Hepatitis B Virus</title><author>Bani-Sadr, F. ; Palmer, P. ; Scieux, C. ; Molina, J. M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c453t-2b2e3b5bf2cb761316193a6bd4b1b7dc29acf39e2bc1d91c7618607d48bff1e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adenine - analogs & derivatives</topic><topic>Adenine - therapeutic use</topic><topic>Adult</topic><topic>AIDS</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antibodies</topic><topic>Biological and medical sciences</topic><topic>DNA</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Hepatitis antigens</topic><topic>Hepatitis B</topic><topic>Hepatitis B - complications</topic><topic>Hepatitis B - drug therapy</topic><topic>Hepatitis B virus</topic><topic>HIV</topic><topic>HIV 1</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - drug therapy</topic><topic>HIV/AIDS</topic><topic>Human immunodeficiency virus 1</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Lamivudine - therapeutic use</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Organophosphonates - therapeutic use</topic><topic>RNA</topic><topic>Tenofovir</topic><topic>Viral diseases</topic><topic>Viral diseases of the digestive system</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Viral hepatitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bani-Sadr, F.</creatorcontrib><creatorcontrib>Palmer, P.</creatorcontrib><creatorcontrib>Scieux, C.</creatorcontrib><creatorcontrib>Molina, J. M.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bani-Sadr, F.</au><au>Palmer, P.</au><au>Scieux, C.</au><au>Molina, J. M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ninety-Six—Week Efficacy of Combination Therapy with Lamivudine and Tenofovir in Patients Coinfected with HIV-1 and Wild-Type Hepatitis B Virus</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2004-10-01</date><risdate>2004</risdate><volume>39</volume><issue>7</issue><spage>1062</spage><epage>1064</epage><pages>1062-1064</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><coden>CIDIEL</coden><abstract>We describe 6 patients who were coinfected with human immunodeficiency virus (HIV) type 1 and wild-type hepatitis B virus (HBV), in whom complete and sustained antiviral activity against wild-type HBV strains was attained during 96 weeks of combination therapy with lamivudine and tenofovir. The use of combination therapy with lamivudine and tenofovir for the treatment of HBV infection is very promising in the treatment of HIV/HBV coinfection.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>15472862</pmid><doi>10.1086/424012</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1058-4838 |
| ispartof | Clinical infectious diseases, 2004-10, Vol.39 (7), p.1062-1064 |
| issn | 1058-4838 1537-6591 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_66955897 |
| source | MEDLINE; JSTOR Archive Collection A-Z Listing; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals |
| subjects | Adenine - analogs & derivatives Adenine - therapeutic use Adult AIDS Anti-HIV Agents - therapeutic use Antibodies Biological and medical sciences DNA Drug Therapy, Combination Female Hepatitis antigens Hepatitis B Hepatitis B - complications Hepatitis B - drug therapy Hepatitis B virus HIV HIV 1 HIV Infections - complications HIV Infections - drug therapy HIV/AIDS Human immunodeficiency virus 1 Human viral diseases Humans Infections Infectious diseases Lamivudine - therapeutic use Male Medical sciences Middle Aged Organophosphonates - therapeutic use RNA Tenofovir Viral diseases Viral diseases of the digestive system Viral diseases of the lymphoid tissue and the blood. Aids Viral hepatitis |
| title | Ninety-Six—Week Efficacy of Combination Therapy with Lamivudine and Tenofovir in Patients Coinfected with HIV-1 and Wild-Type Hepatitis B Virus |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T00%3A39%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ninety-Six%E2%80%94Week%20Efficacy%20of%20Combination%20Therapy%20with%20Lamivudine%20and%20Tenofovir%20in%20Patients%20Coinfected%20with%20HIV-1%20and%20Wild-Type%20Hepatitis%20B%20Virus&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Bani-Sadr,%20F.&rft.date=2004-10-01&rft.volume=39&rft.issue=7&rft.spage=1062&rft.epage=1064&rft.pages=1062-1064&rft.issn=1058-4838&rft.eissn=1537-6591&rft.coden=CIDIEL&rft_id=info:doi/10.1086/424012&rft_dat=%3Cjstor_proqu%3E4462847%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17733008&rft_id=info:pmid/15472862&rft_jstor_id=4462847&rft_oup_id=10.1086/424012&rfr_iscdi=true |